KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) EPS (Weighted Average and Diluted) (2020 - 2025)

Organon has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.78 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.78 for Q4 2025, down 290.24% from a year ago — trailing twelve months through Dec 2025 was $0.72 (down 78.31% YoY), and the annual figure for FY2025 was $0.72, down 78.38%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.78 at Organon, down from $0.61 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for OGN hit a ceiling of $2.13 in Q4 2023 and a floor of -$0.78 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.78 (2021), compared with a mean of $0.85.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 500.0% in 2024 and later plummeted 290.24% in 2025.
  • Organon's EPS (Weighted Average and Diluted) stood at $0.79 in 2021, then tumbled by 46.84% to $0.42 in 2022, then soared by 407.14% to $2.13 in 2023, then tumbled by 80.75% to $0.41 in 2024, then plummeted by 290.24% to -$0.78 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.78 (Q4 2025), $0.61 (Q3 2025), and $0.56 (Q2 2025) per Business Quant data.